Search by Drug Name or NDC

    NDC 69616-0282-90 Fycompa 12 mg/1 Details

    Fycompa 12 mg/1

    Fycompa is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Catalyst Pharmaceuticals, Inc.. The primary component is PERAMPANEL.

    Product Information

    NDC 69616-0282
    Product ID 69616-282_98f5e818-1e3f-43a8-9a56-9c44e639f431
    Associated GPIs
    GCN Sequence Number 069993
    GCN Sequence Number Description perampanel TABLET 12 MG ORAL
    HIC3 H4B
    HIC3 Description ANTICONVULSANTS
    GCN 33276
    HICL Sequence Number 039628
    HICL Sequence Number Description PERAMPANEL
    Brand/Generic Brand
    Proprietary Name Fycompa
    Proprietary Name Suffix n/a
    Non-Proprietary Name perampanel
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 12
    Active Ingredient Units mg/1
    Substance Name PERAMPANEL
    Labeler Name Catalyst Pharmaceuticals, Inc.
    Pharmaceutical Class AMPA Receptor Antagonists [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Noncompetitive AMPA Glutamate Receptor Antagonist [EPC], UGT1A9 Inhibitors [MoA], UGT2B7 Inhibitors [MoA]
    DEA Schedule CIII
    Marketing Category NDA
    Application Number NDA202834
    Listing Certified Through 2025-12-31

    Package

    NDC 69616-0282-90 (69616028290)

    NDC Package Code 69616-282-90
    Billing NDC 69616028290
    Package 90 TABLET in 1 BOTTLE (69616-282-90)
    Marketing Start Date 2024-01-02
    NDC Exclude Flag N
    Pricing Information N/A